Altimmune, Inc. 10-Q filing
Filed 2025-08-12 · Report date 2025-06-30 · 2025
Filing metadata
- Accession number
- 0001326190-25-000040
- Form type
- 10-Q
- CIK
- 0001326190
- Primary document
- https://www.sec.gov/Archives/edgar/data/1326190/000132619025000040/alt-20250630x10q.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Altimmune, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $10,000 | - | - |
| Operating Income | $-44.7M | - | - |
| Net Income | $-41.7M | - | - |
| Eps Basic | -0.53 | - | - |
| Eps Diluted | -0.53 | - | - |
| Cash And Equivalents | $183.1M | - | - |
| Total Assets | $190.3M | - | - |
| Total Liabilities | $29.0M | - | - |
| Shareholders Equity | $161.4M | - | - |
| Operating Cash Flow | $-36.2M | - | - |
| Capital Expenditures | $10,000 | - | - |